Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $69.90 USD
Change Today -2.39 / -3.31%
Volume 5.3M
MDT On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 2:39 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

medtronic plc (MDT) Snapshot

Open
$70.67
Previous Close
$72.29
Day High
$71.06
Day Low
$69.34
52 Week High
03/25/15 - $79.50
52 Week Low
08/24/15 - $55.54
Market Cap
98.3B
Average Volume 10 Days
7.5M
EPS TTM
$3.33
Shares Outstanding
1.4B
EX-Date
09/23/15
P/E TM
20.9x
Dividend
$1.52
Dividend Yield
1.86%
Current Stock Chart for MEDTRONIC PLC (MDT)

medtronic plc (MDT) Details

Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators, implantable cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, and peripheral vascular intervention products. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery, such as ventilators, capnography, and other airway products; sensors; monitors; compression and dialysis products; enteral feeding; wound care; and medical surgical products comprising operating room supply products, electrodes, needles, syringes, and sharps disposals. The company’s Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, and throat; systems that incorporate advanced energy surgical instruments; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps; continuous glucose monitoring systems; insulin pump consumables; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.

92,500 Employees
Last Reported Date: 06/23/15
Founded in 1949

medtronic plc (MDT) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $1.5M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $829.0K
Executive Vice President and Group President ...
Total Annual Compensation: $1.4M
Executive Vice President and Group President ...
Total Annual Compensation: $747.6K
Chief Human Resources Officer and Senior Vice...
Total Annual Compensation: $781.7K
Compensation as of Fiscal Year 2015.

medtronic plc (MDT) Key Developments

Medtronic Announces Cash Dividend for Second Quarter of Fiscal Year 2016, Payable on October 16, 2015

The board of directors of Medtronic plc approved the fiscal year 2016 second quarter cash dividend of $0.38 per ordinary share, representing a 25% increase over the prior year. This quarterly declaration is consistent with the dividend announcement made by the company in June. The dividend is payable on October 16, 2015, to shareholders of record at the close of business on September 25, 2015.

Medtronic plc Launches the Entrust Delivery System in the United States

Medtronic plc announced the launch of its Entrust(TM) delivery system in the United States. The new Entrust delivery system enables physicians to place Medtronic's EverFlex (TM) self-expanding peripheral stent, while maintaining a low profile and providing the ease of a one-handed device. The Entrust delivery system deploys the EverFlex stent to re-open narrowed (stenotic) regions of the superficial femoral and proximal popliteal arteries that supply blood to the legs. Narrowing of these arteries is associated with a condition known as peripheral arterial disease (PAD), where plaque builds along lining of the arteries, blocking blood flow to the legs. The Entrust delivery system provides control and precision with its 5 F triaxial delivery system and its distinctive combination of features, including 0.035" guidewire compatibility, longer catheter lengths, and a broad stent matrix. The Entrust delivery system uses the EverFlex stent, which has been clinically proven to be safe and effective in treating long, complex and highly calcified lesions. In collaboration with leading clinicians, researchers and scientists, Medtronic offers the broadest range of innovative medical technology for the interventional and surgical treatment of cardiovascular diseases and cardiac arrhythmias. The company strives to offer products and services that deliver clinical and economic value to healthcare consumers and providers worldwide.

Medtronic plc Commences Registered Exchange Offer for Certain of its Senior Notes

Medtronic plc announced the commencement of exchange offers with respect to: (i) up to $500,000,000 aggregate principal amount of outstanding Floating Rate Senior Notes due March 15, 2020 issued by Medtronic Inc., together with the subsequent full and unconditional guarantees of such notes by the company and Medtronic Global Holdings S.C.A., for a like principal amount of Floating Rate Senior Notes due March 15, 2020, issued by Medtronic Inc. and guaranteed by the guarantors, which have been registered under the Securities; (ii) up to $1,000,000,000 aggregate principal amount of outstanding 1.500% Senior Notes due March 15, 2018 issued by Medtronic Inc. together with the subsequent full and unconditional guarantees of such notes by the guarantors for a like principal amount of 1.500% Senior Notes due March 15, 2018, issued by Medtronic Inc. and guaranteed by the guarantors, which have been registered under the Securities Act; (iii) up to $2,500,000,000 aggregate principal amount of outstanding 2.500% Senior Notes due March 15, 2020 issued by Medtronic Inc. together with the subsequent full and unconditional guarantees of such notes by the guarantors for a like principal amount of 2.500% Senior Notes due March 15, 2020, issued by Medtronic Inc. and guaranteed by the guarantors, which have been registered under the Securities Act; (iv) up to $2,500,000,000 aggregate principal amount of outstanding 3.150% Senior Notes due March 15, 2022 issued by Medtronic Inc. together with the subsequent full and unconditional guarantees of such notes by the guarantors for a like principal amount of 3.150% Senior Notes due March 15, 2022, issued by Medtronic Inc. and guaranteed by the guarantors, which have been registered under the Securities Act; (v) up to $4,000,000,000 aggregate principal amount of outstanding 3.500% Senior Notes due March 15, 2025 issued by Medtronic Inc. together with the subsequent full and unconditional guarantees of such notes by the guarantors for a like principal amount of 3.500% Senior Notes due March 15, 2025, issued by Medtronic Inc. and guaranteed by the guarantors, which have been registered under the Securities Act; (vi) up to $2,500,000,000 aggregate principal amount of outstanding 4.375% Senior Notes due March 15, 2035 issued by Medtronic Inc. together with the subsequent full and unconditional guarantees of such notes by the guarantors for a like principal amount of 4.375% Senior Notes due March 15, 2035, issued by Medtronic Inc. and guaranteed by the guarantors, which have been registered under the Securities; and (vii) up to $4,000,000,000 aggregate principal amount of outstanding 4.625% Senior Notes due March 15, 2045 issued by Medtronic Inc. together with the subsequent full and unconditional guarantees of such notes by the guarantors for a like principal amount of 4.625% Senior Notes due March 15, 2045, issued by Medtronic Inc. and guaranteed by the guarantors, which have been registered under the Securities Act. The exchange offers will commence on August 4, 2015 and expire at 11:59 p.m., New York City time, on August 31, 2015. Medtronic Inc. will accept for exchange any and all original notes validly tendered and not validly withdrawn prior to 11:59 p.m., New York City time, on August 31, 2015, unless the exchange offers are extended or terminated.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDT:US $69.88 USD -2.41

MDT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $60.72 USD -1.69
Allergan plc $296.72 USD -7.02
Amgen Inc $149.09 USD -2.69
Bristol-Myers Squibb Co $58.65 USD -0.82
Eli Lilly & Co $80.19 USD -2.16
View Industry Companies
 

Industry Analysis

MDT

Industry Average

Valuation MDT Industry Range
Price/Earnings 30.5x
Price/Sales 5.2x
Price/Book 2.0x
Price/Cash Flow 30.5x
TEV/Sales 2.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDTRONIC PLC, please visit www.medtronic.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.